Infective endocarditis due to unusual or fastidious microorganisms

被引:169
作者
Berbari, EF
Cockerill, FR
Steckelberg, JM
机构
[1] MAYO CLIN & MAYO FDN,DIV INFECT DIS & INTERNAL MED,ROCHESTER,MN 55905
[2] MAYO CLIN & MAYO FDN,DIV CLIN MICROBIOL,ROCHESTER,MN 55905
关键词
D O I
10.4065/72.6.532
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Infective endocarditis due to fastidious microorganisms is-commonly encountered in clinical practice. Some organisms such as fungi account for up to 15% of cases of prosthetic valve infective endocarditis, whereas organisms of the HACEK group (Haemophilus parainfluenzae, H. aphrophilus, and H. paraphrophilus, Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, Eikenella corrodens, and Kingella kingae) cause 3% of community-acquired cases of infective endocarditis. Special techniques are necessary to identify these microorganisms. A history of contact with mammals or birds may suggest infection caused by Coxiella burnetii (Q fever), Brucella species, or Chlamydia psittaci, A nosocomial cluster of postsurgical infective endocarditis may be caused by Legionella species or Mycobacterium species. If risk factors that are commonly associated with fungal infections (cardiac surgical treatment, prolonged hospitalization, indwelling central venous catheters, and long-term antibiotic use) are present, fungal endocarditis is possible. Patients with endocarditis and a history of periodontal disease or dental work in whom routine blood cultures are negative might have infection due to nutritionally variant streptococci or bacteria of the HACEK group. Communication between the microbiologist and the clinician is of crucial importance for identification of these microorganisms early during the course of the infection before complications such as embolization or valvular failure occur. In this article, we review the microbiologic and clinical features of these organisms and provide recommendations for diagnosis and treatment.
引用
收藏
页码:532 / 542
页数:11
相关论文
共 78 条
  • [1] QUINOLONES IN TREATMENT OF HUMAN BRUCELLOSIS - COMPARATIVE TRIAL OF OFLOXACIN-RIFAMPIN VERSUS DOXYCYCLINE-RIFAMPIN
    AKOVA, M
    UZUN, O
    AKALIN, HE
    HAYRAN, M
    UNAL, S
    GUR, D
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) : 1831 - 1834
  • [2] MANAGEMENT OF BRUCELLA ENDOCARDITIS WITH AORTIC ROOT ABSCESS
    ALKASAB, S
    ALFAGIH, M
    ALRASHEED, A
    KHAN, B
    BITAR, I
    SHAHED, M
    SAWYER, W
    [J]. CHEST, 1990, 98 (06) : 1532 - 1534
  • [3] MYCOBACTERIUM-FORTUITUM ENDOCARDITIS AFTER MITRAL-VALVE REPLACEMENT WITH A BOVINE PROSTHESIS
    ALVAREZELCORO, S
    MATEOSMORA, M
    ZAJARIAS, A
    [J]. SOUTHERN MEDICAL JOURNAL, 1985, 78 (07) : 865 - 866
  • [4] AYRAL X, 1989, ANN MED INTERNE, V140, P652
  • [5] BOURRET N, 1995, ANN MED INTERNE, V146, P137
  • [7] COMPARISON OF PENICILLIN AND VANCOMYCIN, INDIVIDUALLY AND IN COMBINATION WITH GENTAMICIN AND AMIKACIN, IN THE TREATMENT OF EXPERIMENTAL ENDOCARDITIS INDUCED BY NUTRITIONALLY VARIANT STREPTOCOCCI
    BOUVET, A
    CREMIEUX, AC
    CONTREPOIS, A
    VALLOIS, JM
    LAMESCH, C
    CARBON, C
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (05) : 607 - 611
  • [8] IMMUNOHISTOLOGIC DEMONSTRATION OF COXIELLA-BURNETII IN THE VALVES OF PATIENTS WITH Q-FEVER ENDOCARDITIS
    BROUQUI, P
    DUMLER, JS
    RAOULT, D
    [J]. AMERICAN JOURNAL OF MEDICINE, 1994, 97 (05) : 451 - 458
  • [9] BROUQUI P, 1993, ARCH INTERN MED, V153, P642, DOI 10.1001/archinte.153.5.642
  • [10] BUTANY J, 1993, CAN J CARDIOL, V9, P214